This is a preliminary report on the treatment of 7 patients with multiple myeloma with antimony compounds. The therapeutic trial was based on the fact that multiple myeloma is frequently associated with hyperglobulinemia, a characteristic shared with other diseases in which antimony had been found therapeutically effective.

The results obtained thus far are insufficient to warrant conclusions, although they indicate a possible influence of antimony on myeloma tissue. This influence is seen mainly as an increased radiosensitivity when patients are subsequently treated with x-rays.

This content is only available as a PDF.